Friday 16 October 2015

Anesthesia Monitoring Devices Market by Product & End User Forecast to 2020

The global anesthesia monitoring devices market report defines and segments the market with analysis and forecast of revenue. The global anesthesia monitoring devices market was valued at USD 820.9 million in 2014 and is projected to reach USD 1,616 million by 2020, at a CAGR of 12.0% from 2015 to 2020.

Anesthesia monitoring devices are available as a part of sophisticated multi-parameter patient monitors, or as a component of a high-end anesthesia workstation, or as a standalone unit. Technological changes as well as the growing usage of anesthesia monitors in the freestanding surgery centers are contributing to the increased growth of the anesthesia monitor devices market. The global market is expected to grow due to the rise in aging population, increasing number of surgeries, growing awareness among physicians, and advancements in technology. Despite this, high cost of anesthesia monitoring devices and the availability of conventional techniques are the major restraining factors of this market.

                                  Image Credit: Google

This market is segmented and forecasted on the basis of product, end user, and geography. The product comprises of advanced anesthesia monitors, basic anesthesia monitors, integrated anesthesia workstation, and others (IT enabled). The advanced anesthesia monitors are further subsegmented into anesthesia gas monitors, depth of anesthesia, standalone capnography monitors, and others (MRI compatible anesthesia monitors). On the basis of end user, the market is segmented into hospitals and ambulatory surgery centers. The market is further segmented and forecasted on the basis of major regions, which include North America, Europe, Asia-pacific and the rest of the world (RoW).

In 2014, 31.5% of the global anesthesia monitoring devices market was dominated by North America. The market in North America is growing due to increased patient safety and awareness among doctors and patients for low flow aesthetic agents. The European market, growing due to technological advancements, has been dominated majorly by Drägerwerk AG & Co. KGaA. However, the North American and European markets are moving toward the maturity phase.

This report also includes the market share, approaches for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis, and price analysis by product. In this report, market metrics are also included, such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profile of key players in the market, including major companies which provide anesthesia monitoring devices as a product.

Thursday 15 October 2015

Breast Imaging Technologies Market Trends and Forecast by 2019

In 2013, the global breast imaging technologies market was dominated by GE Healthcare (U.K.), Hologic, Inc. (U.S.), Philips Healthcare (Netherlands), and Siemens Healthcare (Germany). Hologic, Inc. is the leader in the global mammography market and is expected to lead the market in the next five years as well. The company owns a wide product portfolio including a range of mammography systems, breast ultrasound systems, and MRI solutions. Selenia Mammography systems and Selenia Dimensions 3D Breast Tomosynthesis systems are some of the most popular brands of the breast imaging technologies offered by Hologic, Inc. As of September 2013, the company employed more than 5,615 people. It markets its products across North America, Europe, Central America, Australia, and Asia. The company’s wide range of product offerings coupled with its wide geographic presence enables it to maintain its leading position in the global breast imaging technologies market. Furthermore, the company focuses on research and development of innovative products as its key business strategy to ensure growth in the global breast imaging technologies market.    

                                                   Image Source: Google 
Besides, Hologic, Inc., GE Healthcare is also one of the major players in the global breast imaging technologies market. Over the past three years, the company has been focusing on strategic acquisitions, agreements, and joint ventures as its key business strategies in order to increase its share in the global breast imaging technologies market. The company has a wide product portfolio including mammography, computed tomography, and MRI (Magnetic Resonance Imaging) systems, which serve as an important factor for its future growth. SenoClaire, Discovery, VIBRANT, and IDEAL are the breast imaging system brands offered by the company. It has a strong geographic presence and large customer base.

In the global breast imaging technologies market, leading players are adopting the strategies of new product launches, product approvals, partnerships, agreements, collaborations, joint ventures, acquisitions, and expansions. Market players adopted these strategies to access new technologies, expand their product portfolios, enter the growing markets, and to increase their market shares. In addition to the top market players, companies such as Aurora Imaging Technologies, Inc. (U.S.), Dune Medical Devices (U.S.), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan), also primarily focus towards launching  new breast imaging systems, product approvals, and strategic agreements, partnerships, and collaborations to widen their customer base.

Major strategic developments are taking place in the field of 3D breast tomosynthesis and optical imaging technologies market, which exhibit high-growth potential in the near future. Dominant market players such as GE Healthcare (U.K.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), and Siemens AG (Germany) introduced several technologically advanced systems, and entered into strategic agreements and partnerships in order to keep pace with the industry trends. 



Wednesday 14 October 2015

Global Respiratory Care Devices Market trends and Forecast by 2020

The global respiratory care devices market is poised to grow at a CAGR of around 9.6% from 2015 to 2020. Factors such as rising incidences of respiratory diseases, increasing geriatric population, growing focus on monitoring respiratory diseases, rising demand for home healthcare, and growing Asian market are driving the growth of the respiratory care devices market.                

               
                                   Image Credit : Google 

In 2014, the therapeutic devices segment accounted for around 60% to 65% of the global respiratory care devices market. The key factor driving the growth of this market is the rising incidences of chronic diseases. In addition, the global growth in elderly population is expected to support the growth of the respiratory therapeutic devices market in the coming years. The rise in illness severity and hospitalization costs have led to the greater use of monitoring devices. 

Patients are advised by doctors to continuously monitor disease conditions before it aggravates. Patients also prefer continuous monitoring to prevent suffering at later stages and to prevent costly hospitalization. In addition, increasing research activities and financial support from public-private organizations are impelling the growth of the respiratory care devices market. Home care is the fastest-growing end-user market for respiratory care devices. Home care respiratory care devices are convenient and can be used in the comfort of a patient’s home. This is a key factor driving the growth of the respiratory care devices market for the home care segment. North America and Europe are the key respiratory care devices markets for the home care segment, owing to the presence of well-developed healthcare and health insurance infrastructure in these regions.

The APAC market is expected to witness the highest growth rate during the forecast period. Growth in this geographic segment can primarily be attributed to the presence of high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. Low labor costs and favorable regulatory environment in this region are expected to further propel market growth. China is expected to be the most lucrative market in the Asia-Pacific region during the forecast period, owing to factors such as the growing prevalence of lifestyle-related diseases such as obesity, decreasing mortality rate, and rising demand for home healthcare in the country.